However, the more common genetic alterations used as cancer biomarkers are mutations involving a single nucleotide (single nucleotide variants or SNVs) or a few nucleotides (small insertions and deletions or indels), e.g., driver mutations in EGFR, KRAS, BRAF, TP53, KITK, and other genes. This evidence concerns the gene KRAS and cancer.